| |
| |
|
| Insider
Information: |
Wigginton Jon Marc |
| Relationship: |
Sr VP, Clinical Dev. &... |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
18,930 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$275,621 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,930 |
|
|
| Total
Value |
$275,621 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Macrogenics Inc |
MGNX |
Sr VP, Clinical Dev. &... |
2018-02-26 |
18,930 |
2014-08-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2018-02-26 |
4 |
D |
$23.46 |
$259,702 |
D/D |
(11,070) |
18,930 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2018-01-17 |
4 |
AS |
$20.00 |
$50,480 |
D/D |
(2,524) |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2018-01-17 |
4 |
OE |
$4.70 |
$11,863 |
D/D |
2,524 |
32,524 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2018-01-16 |
4 |
AS |
$20.00 |
$49,520 |
D/D |
(2,476) |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2018-01-16 |
4 |
OE |
$4.70 |
$11,637 |
D/D |
2,476 |
32,476 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-11-21 |
4 |
OE |
$4.70 |
$23,500 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-11-21 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-10-25 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-10-25 |
4 |
OE |
$4.70 |
$47,000 |
D/D |
10,000 |
40,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-06-05 |
4 |
OE |
$4.70 |
$23,500 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-06-05 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-04-19 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2017-04-19 |
4 |
OE |
$4.70 |
$70,500 |
D/D |
15,000 |
45,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2016-10-03 |
5 |
S |
$29.34 |
$293,400 |
D/D |
(10,000) |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2016-10-03 |
4 |
AS |
$29.34 |
$293,400 |
D/D |
(10,000) |
0 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
• – – |
2016-10-03 |
4 |
OE |
$4.70 |
$47,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP Clinical Dev & CMO |
• – – |
2016-08-01 |
4 |
AS |
$30.78 |
$615,600 |
D/D |
(20,000) |
0 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP Clinical Dev & CMO |
• – – |
2016-08-01 |
4 |
OE |
$4.70 |
$94,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP Clinical Dev & CMO |
• – – |
2016-07-01 |
4 |
AS |
$27.22 |
$136,100 |
D/D |
(5,000) |
0 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP Clinical Dev & CMO |
• – – |
2016-07-01 |
4 |
OE |
$4.70 |
$23,500 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev & CMO |
• – – |
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical |
• – – |
2016-01-04 |
4 |
AS |
$29.64 |
$296,400 |
D/D |
(10,000) |
0 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical |
• – – |
2016-01-04 |
4 |
OE |
$4.70 |
$47,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical |
• – – |
2015-10-01 |
4 |
AS |
$21.11 |
$105,550 |
D/D |
(5,000) |
0 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Clinical |
• – – |
2015-10-01 |
4 |
OE |
$4.70 |
$23,500 |
D/D |
5,000 |
5,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
